Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

Pueraria thunbergiana extract may help prevent hair from turning gray.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tridax procumbens plant parts boost immune response in mice.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

TIP39 and PTH2R help control calcium levels and skin cell development.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

AIMP1 can boost hair growth by increasing stem cell activity.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.